| Waning immunity against respiratory syncytial virus during the coronavirus disease 2019 pandemic F Reicherz, RY Xu, B Abu-Raya, A Majdoubi, C Michalski, L Golding, ... The Journal of infectious diseases 226 (12), 2064-2068, 2022 | 101 | 2022 |
| Immunogenicity of extended mRNA SARS-CoV-2 vaccine dosing intervals B Grunau, DM Goldfarb, M Asamoah-Boaheng, L Golding, TL Kirkham, ... Jama 327 (3), 279-281, 2022 | 78 | 2022 |
| Correlation of SARS-CoV-2 viral neutralizing antibody titers with anti-spike antibodies and ACE-2 inhibition among vaccinated individuals B Grunau, M Prusinkiewicz, M Asamoah-Boaheng, L Golding, PM Lavoie, ... Microbiology Spectrum 10 (5), e01315-22, 2022 | 25 | 2022 |
| Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy ZJ Shire, F Reicherz, S Lawrence, H Sudan, L Golding, A Majdoubi, ... Gut 71 (9), 1922-1924, 2022 | 16 | 2022 |
| Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures F Reicherz, L Golding, PM Lavoie, B Abu-Raya Vaccine 40 (27), 3746-3751, 2022 | 14 | 2022 |
| Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination GR Lunken, L Golding, A Schick, A Majdoubi, PM Lavoie, BA Vallance Gut 73 (1), 208-210, 2024 | 13 | 2024 |
| Comparative 6-month wild-type and Delta-variant antibody levels and surrogate neutralization for adults vaccinated with BNT162b2 versus mRNA-1273 B Grunau, L Golding, MA Prusinkiewicz, M Asamoah-Boaheng, R Armour, ... Microbiology Spectrum 10 (2), e02702-21, 2022 | 4 | 2022 |
| Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity M Asamoah-Boaheng, D Goldfarb, MA Prusinkiewicz, L Golding, ... Cureus 15 (1), 2023 | 3 | 2023 |
| A Novel Anti-nucleocapsid Antibody Avidity Method for Identifying SARS-CoV-2 Reinfections L Golding, AW Watts, J Shew, M Viñeta Paramo, LC Mâsse, DM Goldfarb, ... The Journal of Infectious Diseases, jiae072, 2024 | 2 | 2024 |
| Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation Measures B Abu-Raya, F Reicherz, C Michalski, M Viñeta Paramo, A Majdoubi, ... Journal of the Pediatric Infectious Diseases Society 12 (12), 642-645, 2023 | 2 | 2023 |
| Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections L Golding, AW Watts, M Pitblado, F Clemens, M Viñeta Paramo, J Shew, ... Open Forum Infectious Diseases 11 (10), ofae608, 2024 | | 2024 |
| 210 A multimorphic variant in ThPOK causes a novel human disease characterized by T cell immune developmental abnormalities, immunodysregulation, atopy, and organ fibrosis M Vaseghi-Shanjani, M Sharma, P Yousefi, S Samra, K Laverty, A Jolma, ... Clinical Immunology 262, 110152, 2024 | | 2024 |
| DDIT4L regulates mitochondrial and innate immune activities in early life C Michalski, C Cheung, JH Oh, E Ackermann, CR Popescu, ... JCI insight 9 (5), 2024 | | 2024 |
| A multimorphic variant in ThPOK causes a novel human disease characterized by T cell abnormalities, immunodysregulation, allergy, and fibrosis M Vaseghi-Shanjani, M Sharma, P Yousefi, S Samra, KU Laverty, A Jolma, ... medRxiv, 2024.06. 26.24309360, 2024 | | 2024 |
| Profiling antibody immunity to SARS-CoV-2 mRNA vaccination L Golding University of British Columbia, 2023 | | 2023 |
